Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis

Journal of Investigative Medicine

Volumn 64, Issue 6, 2016, Pages 1148-1150

  Crouser, Elliott D ^a   Ruden, Emily ^a   Julian, Mark W ^a   Raman, Subha V ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SARCOIDOSIS; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; SARCOIDOSIS;

EID: 85006158741     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.1136/jim-2016-000144     Document Type: Article

References (12)

1. Swigris JJ, Olson AL, Huie TJ, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011;183:1524-30.
2. Rosenthal DG, Bravo PE, Patton KK, et al. Management of arrhythmias in cardiac sarcoidosis. Clin Cardiol 2015;38:635-40.
3. Zipse MM, Sauer WH. Cardiac sarcoidosis and consequent arrhythmias. Card Electrophysiol Clin 2015;7:235-49.
4. Wassmuth R, Schultz-Menger J. Cardiovascular magnetic resonance imaging of myocardial inflammation. Expert Rev Cardiovasc Ther 2011;9:1193-201.
5. Birnie DH, Sauer W, Bogun F, et al. Heart Rhythm Society expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1-24.
6. Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using t2 mapping. Circ Cardiovasc Imaging 2012;5:102-10.
7. Nagai S, Yokomatsu T, Tanizawa K, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med 2014;53:427-33.
8. Zhang Y, Corona-Villalobos CP, Kiani AN, et al. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus. Int J Cardiovasc Imaging 2015;31:389-97.
9. Mavrogeni S, Bratis K, Markussis V, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013;22:34-43.
10. Sado DM, Kozor R, Corr L, et al. Global myocardial edema in antisynthetase syndrome detected by cardiovascular magnetic resonance mapping techniques. Circulation 2016;133:e25-26.
11. Crouser ED, Ono C, Tran T, et al. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med 2014;189:109-12.
12. Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012;9:884-91.